Intraocular pressure measurements after corneal collagen crosslinking with riboflavin and ultraviolet A in eyes with keratoconus.

Détails

ID Serval
serval:BIB_0D2D8602207B
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Intraocular pressure measurements after corneal collagen crosslinking with riboflavin and ultraviolet A in eyes with keratoconus.
Périodique
Journal of cataract and refractive surgery
Auteur⸱e⸱s
Kymionis G.D., Grentzelos M.A., Kounis G.A., Portaliou D.M., Detorakis E.T., Magarakis M., Karampatakis V.E., Pallikaris I.G.
ISSN
1873-4502 (Electronic)
ISSN-L
0886-3350
Statut éditorial
Publié
Date de publication
10/2010
Peer-reviewed
Oui
Volume
36
Numéro
10
Pages
1724-1727
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
To determine the possible effect of corneal collagen crosslinking (CXL) with riboflavin and ultraviolet A (UVA) on intraocular pressure (IOP) measurements by Goldmann applanation tonometry (GAT).
Institute of Vision and Optics, Faculty of Medicine, University of Crete, Heraklion, Crete, Greece.
Prospective case series.
This noncomparative study measured IOP by GAT before CXL and 6 months and 12 months after CXL.
The study evaluated 55 eyes (55 patients). There was a statistically significant increase in the measured IOP 6 months and 12 months after CXL (both P<.001). The mean measured IOP was 9.95 mm Hg ± 3.01 (SD) before CXL, 11.40 ± 2.89 mm Hg at 6 months, and 11.35 ± 3.38 mm Hg at 12 months. The change in IOP measurements at both postoperative examinations was not correlated with patient age, preoperative pachymetry, or preoperative keratometry readings.
After riboflavin-UVA CXL in eyes with keratoconus, there was a significant increase in IOP measured by GAT that was probably caused by an increase in corneal rigidity.
Mots-clé
Adolescent, Adult, Collagen/metabolism, Cornea/metabolism, Cross-Linking Reagents, Humans, Intraocular Pressure/physiology, Keratoconus/drug therapy, Keratoconus/metabolism, Photochemotherapy, Photosensitizing Agents/therapeutic use, Prospective Studies, Riboflavin/therapeutic use, Time Factors, Tonometry, Ocular, Ultraviolet Rays, Young Adult
Pubmed
Web of science
Création de la notice
01/10/2019 16:13
Dernière modification de la notice
06/10/2019 6:26
Données d'usage